Friday, April 12, 2024
Home Tags Preclinical

Tag: Preclinical

Cellectis Publishes Article in Frontiers in Immunology Unveiling Pre-Clinical Da… –...

0
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) -- Cellectis (the "Company") CLLS, a clinical-stage biotechnology company using its pioneering gene-editing platform...

Medicenna Presents Preclinical IL-13 Superkine Data at the AACR Annual Meeting...

0
-- IL-13 Superkines provide a versatile strategy for targeted delivery of anti-cancer agents to IL-13Rα2, which is overexpressed in many solid tumors but...

Preclinical Data on Volastra Therapeutics’ Two Novel and Differentiated KIF18A I…...

0
Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), today released preclinical data from the company's portfolio of KIF18A...

Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Uni… –...

0
Broad response demonstrated through deep cyclic inhibition of MAPK pathway, independent of specific RAS mutationPhase 1/2a clinical trial with IMM-1-104 underway in patients...

FSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Effic…...

0
FSD Pharma releases new corporate video providing insight on the Company's innovation to help millions of people suffering from Multiple Sclerosis Morningstar releases research...

Global Preclinical Brain Imaging Market Report 2022: Rising Awareness of Early...

0
DUBLIN, Feb. 20, 2023 /PRNewswire/ -- The "Global Preclinical Brain Imaging Market, By Imaging Type, By End User, Estimation & Forecast, 2017-2030" report...

Jaguar Gene Therapy Announces Preclinical Data Presentations at Upcoming America… –...

0
- Accepted abstracts include preclinical data on JAG101, an investigational gene therapy designed to address the root cause of Type 1 galactosemia Jaguar Gene...

Nektar and Collaborators Present Preclinical Data on NKTR-255, a Novel IL-15...

0
SAN FRANCISCO, April 23, 2022 /PRNewswire/ -- Nektar Therapeutics NKTR announced that collaborators from the Cairo Laboratory at New York Medical College today...

PIC Therapeutics to Present Pre-Clinical Data on eIF4E Program to Address...

0
PIC Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first-in-mechanism, first-in-class allosteric therapies targeting eIF4E, today announced it will present...

Ascletis Announces the Latest Results of the Preclinical Studies of Two...

0
HANGZHOU, China and SHAOXING, China, March 27, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) today announces that the latest preclinical research results of the...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News